Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438670 · ClinicalTrials.gov registry record · NA
MPC Versus PID for Closed Loop Insulin Delivery
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02438670 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT02438670, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this proposed study is to compare use of a PID (Proportional-Integral-Derivative) controller versus an MPC (Model Predictive Control) controller algorithm in an artificial pancreas system, all other components and study design being equal. The study design, power calculation and endpoints were developed based on the results of an initial feasibility study (ClinicalTrials.gov Identifier: NCT01987206) that has already been completed.
Interventions
- DEVICE PID control algorithm
- DEVICE MPC control algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438670
The ClinicalTrials.gov registry entry for NCT02438670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PID control algorithm is the first listed.
NCT02438670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438670 about?
NCT02438670 is a clinical study titled "MPC Versus PID for Closed Loop Insulin Delivery". The goal of this proposed study is to compare use of a PID (Proportional-Integral-Derivative) controller versus an MPC (Model Predictive Control) controller algorithm in an artificial pancreas system, all other components and study design being equal. The study design, power calculation and endpoint...
What is the current status of trial NCT02438670?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-05. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02438670?
The interventions under investigation include: PID control algorithm (DEVICE), MPC control algorithm (DEVICE).
Who is sponsoring clinical trial NCT02438670?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.